Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.

Wrobel, Antoni G; Benton, Donald J; Hussain, Saira; Harvey, Ruth; Martin, Stephen R; Roustan, Chloë; Rosenthal, Peter B; Skehel, John J; Gamblin, Steven J

s41467-020-19146-5.pdf (909.07 kB)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.

journal contribution

posted on 2020-10-26, 09:30 authored by Antoni G Wrobel, Donald J Benton, Saira Hussain, Ruth Harvey, Stephen R Martin, Chloë Roustan, Peter B Rosenthal, John J Skehel, Steven J Gamblin

The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.

Funding

Crick (Grant ID: 10143, Grant title: Rosenthal FC001143) Crick (Grant ID: 10078, Grant title: Gamblin FC001078) Crick (Grant ID: 10030, Grant title: McCauley FC001030)

History

Publisher DOI

https://doi.org/10.1038/s41467-020-19146-5

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.

Funding

Crick (Grant ID: 10143, Grant title: Rosenthal FC001143) Crick (Grant ID: 10078, Grant title: Gamblin FC001078) Crick (Grant ID: 10030, Grant title: McCauley FC001030)

History

Publisher DOI

Usage metrics

Categories

Keywords

Licence

Exports